Effects of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370, fenilprenazone) on lysosomes.
D000135:Acid Phosphatase; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D007249:Inflammation / Q000139:chemically induced / Q000201:enzymology; D007616:Kaolin; D008247:Lysosomes / Q000187:drug effects* / Q000201:enzymology; D008566:Membranes / Q000187:drug effects; D010653:Phenylbutazone / Q000494:pharmacology; D011719:Pyrazines / Q000494:pharmacology*; D051381:Rats
D000893:Anti-Inflammatory Agents; D011719:Pyrazines; D007616:Kaolin; D000135:Acid Phosphatase; D010653:Phenylbutazone